Valuation (64%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 7.04 | N/A |
PEG Ratio (TTM) | 0.07 | N/A |
P/S Ratio (TTM) | 35.44 | N/A |
P/B Ratio (TTM) | 1.01 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | 4.89 | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (75%) |
Company | Industry |
---|---|---|
ROA (TTM) | 13.98% | N/A |
ROE (TTM) | 14.88% | N/A |
Net Profit Margin (TTM) | 503.61% | N/A |
ROIC 5YR AVG | 18.61% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 1,433.25% | 206.14% | 127.70% |
Revenue | 98.76% | 604.57% | 360.98% |
Net Income | 1,428.43% | 609.30% | 381.99% |
Cash Flow | N/A | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | N/A | N/A |
Quick Ratio (TTM) | N/A | N/A |
D/E Ratio (TTM) | 0.00 | N/A |
Interest Coverage (TTM) | 34,049.48 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 24.69 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | 1.68% | N/A |